TITLE

When will the bear move on?

AUTHOR(S)
Brower, Vicki
PUB. DATE
November 2002
SOURCE
EMBO Reports;Nov2002, Vol. 3 Issue 11, p1015
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article reports on problems faced by biotechnology industry in the U.S. in 2002. The year 2002 has not been kind to biotechnology: the industry has lost nearly half its value since January. Recent rejections of new drug applications from various bio-technology companies by the U.S. Food and Drug Administration (FDA ) have led to a general downturn of the stocks of companies with similar drugs in the pipeline. Bad news from clinical trials and new FDA regulations for drug development have also meant plunges in stock prices. More drug rejections will follow as the number of new drug applications has increased.
ACCESSION #
12957187

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics